Prospect Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Buy
1,385
+29
+2% +$29.4K 0.78% 32
2025
Q4
$1.46M Buy
1,356
+85
+7% +$81.3K 0.84% 29
2025
Q3
$970K Sell
1,271
-300
-19% -$223K 0.56% 40
2025
Q2
$1.22M Sell
1,571
-231
-13% -$180K 0.76% 31
2025
Q1
$1.49M Buy
1,802
+61
+4% +$50.8K 0.83% 29
2024
Q4
$1.34M Buy
1,741
+175
+11% +$145K 0.73% 31
2024
Q3
$1.39M Buy
1,566
+286
+22% +$257K 0.86% 27
2024
Q2
$1.16M Sell
1,280
-270
-17% -$216K 0.89% 28
2024
Q1
$1.21M Buy
1,550
+146
+10% +$104K 1% 27
2023
Q4
$818K Buy
+1,404
New +$820K 0.83% 28

Other funds holding LLY

Prospect Financial Services's LLY Position: Q1 2026 in Review

Prospect Financial Services increased its Eli Lilly (LLY) stake by 2.1% in Q1 2026, buying an estimated $29.4K and bringing the position to 1,385 shares worth $1.27M. The position accounts for 0.78% of the portfolio, ranked #32.

Prospect Financial Services first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.49M in Q1 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Prospect Financial Services held 1,385 shares of Eli Lilly worth $1.27M as of Q1 2026.
  • Prospect Financial Services bought 29 Eli Lilly shares in Q1 2026, an estimated $29.4K.
  • Eli Lilly made up 0.78% of Prospect Financial Services's portfolio in Q1 2026, its #32 holding.
  • Prospect Financial Services first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Prospect Financial Services's Eli Lilly position peaked at $1.49M in Q1 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Prospect Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.